The brain-computer interface (BCI) sector is witnessing an unprecedented financial acceleration. In under nine months, companies specializing in this technology have raised over $1 billion—a figure that underscores growing investor interest in a field long confined to university labs. While Neuralink, led by Elon Musk, has long dominated the media spotlight, it now faces diverse competition, ranging from U.S. start-ups like Precision Neuroscience to a myriad of international players. To date, fewer than 200 people worldwide have received such an implant, confirming that we are still in the early stages of a therapeutic revolution aimed at restoring speech or mobility through a direct connection between neurons and machines.
Technologically, three distinct approaches are competing. The most invasive method involves inserting electrodes directly into brain tissue for precise, long-term reading. A more conservative alternative involves placing sensors on the brain's surface, thereby avoiding any penetration of the gray matter, while a third path explores non-invasive sensors placed on the scalp. The latter, however, suffers from a signal weakened by the skull, which currently limits its operational effectiveness. At the same time, artificial intelligence is becoming a key catalyst: giants like OpenAI, through its involvement in Merge Labs, are injecting massive resources to optimize the interpretation of neural data.
The global race for technological leadership is intensifying, exacerbating geopolitical disparities. The U.S. maintains a notable lead thanks to a dynamic venture capital ecosystem and regulations, driven by the FDA, that are considered more agile than those of its European counterparts. Despite a solid innovation pipeline, Europe suffers from fragmented funding and a complex regulatory framework that forces some companies to conduct their clinical trials across the Atlantic. For its part, China has officially classified the field of neural interfaces among its national strategic priorities, aiming for the emergence of two to three global champions by 2030, supported by privileged access to a large patient pool.
The challenges of tomorrow go beyond mere control of digital interfaces. The development of "closed-loop" systems represents the next step, allowing not only for the reading of brain activity but also for sending electrical stimulation back to promote, for example, neural reconnection after a stroke. Combining these interfaces with advanced robotic prosthetics promises to offer unprecedented motor and sensory capabilities. However, the long-term viability of this sector rests on major clinical hurdles: demonstrating the reliability of implants over the long term, obtaining approvals for permanent devices, and the ability of companies to move from a phase of technological promise to a widespread medical reality.